In our prospective, single-center pilot study, we enrolled patients with ulcerative colitis (UC), a chronic inflammatory bowel disease (IBD) in which tumor necrosis factor-α (TNF-α) activity is well documented even during remission [20]. This evidence concerns the gene TNF and ulcerative colitis.